Burt H M, Jackson J K
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
J Rheumatol. 1990 Oct;17(10):1359-63.
Intact, human erythrocytes were pretreated with membrane permeable, dimethyl adipimidate (DMA) and dimethyl suberimidate (DMS) and membrane impermeable 3,3' dithiobis (sulfosuccinimidylpropionate) (DTSSP) protein crosslinking agents and incubated with monosodium urate monohydrate (MSUM) crystals. The percent inhibition of lysis values for pretreated cells relative to untreated cells were determined. All 3 agents caused a concentration dependent inhibition of MSUM induced hemolysis that was not due to a decrease in MSUM binding to the pretreated membranes. It was proposed that the inhibition of lysis was due to crosslinking of integral and cytoskeletal membrane proteins, resulting in a reduced mobility of the proteins, inhibition of lateralization of integral proteins into aggregates and decreased "pore" formation in the membrane.
完整的人类红细胞先用可透过膜的己二酸二甲酯(DMA)和辛二酸二甲酯(DMS)以及不可透过膜的3,3'-二硫代双(磺基琥珀酰亚胺丙酸酯)(DTSSP)蛋白质交联剂进行预处理,然后与一水合尿酸钠(MSUM)晶体一起孵育。测定预处理细胞相对于未处理细胞的溶血抑制率。所有这三种试剂均引起MSUM诱导的溶血的浓度依赖性抑制,这并非由于MSUM与预处理膜的结合减少所致。有人提出,溶血抑制是由于整合膜蛋白和细胞骨架膜蛋白的交联,导致蛋白质迁移率降低、整合蛋白侧向聚集受到抑制以及膜中“孔”形成减少。